These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15631882)

  • 21. Genetic analysis of the glucose-6-phosphate dehydrogenase deficiency in a southern Croatia.
    Terzić J; Krzelj V; Drmić I; Andelinović S; Primorac D; Mestrović J; Balarin L
    Coll Antropol; 1998 Dec; 22(2):485-9. PubMed ID: 9887604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
    Middeldorp S; van der Meer J
    Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of G6PD deficiency in India.
    Sukumar S; Mukherjee MB; Colah RB; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):141-5. PubMed ID: 15315792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.
    Barišić M; Korać J; Pavlinac I; Krželj V; Marušić E; Vulliamy T; Terzić J
    J Hum Genet; 2005; 50(11):547-549. PubMed ID: 16143877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular analysis of glucose-6-dehydrogenase deficiency in Spain].
    Vives Corrons JL; Zarza R; Aymerich JM; Boixadera J; Carrera A; Colomer D; Corbella M; Castro M; Crespo JM; Del Arco A; Erkiaga S; Font L; González I; Juncá J; Lausin A; Manrubia E; Martín Núñez G; Murga MJ; Oliva E; Pérez de Mendiguren B; Pujades MA; Remacha A; Rovira A; Villegas A
    Sangre (Barc); 1997 Oct; 42(5):391-8. PubMed ID: 9424740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
    Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation.
    Brown K; Luddington R; Taylor SA; Lillicrap DP; Baglin TP
    Br J Haematol; 1999 Apr; 105(1):95-7. PubMed ID: 10233369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of Mediterranean mutation among a group of Saudi G6PD patients in Western region-Jeddah.
    Gari MA; Chaudhary AG; Al-Qahtani MH; Abuzenadah AM; Waseem A; Banni H; Al-Sayes FM; Al-Harbi A; Lary S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):17-21. PubMed ID: 20447239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor V Leiden: a case study and review.
    Slusher KB
    Dimens Crit Care Nurs; 2010; 29(1):6-10. PubMed ID: 20010186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid genotyping of two common G6PD variants, African (A-) and Mediterranean, by high-resolution melting analysis.
    Joly P; Lacan P; Garcia C; Martin C; Francina A
    Clin Biochem; 2010 Jan; 43(1-2):193-7. PubMed ID: 19782058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area.
    Turri D; Rosselli M; Simioni P; Tormene D; Grimaudo S; Martorana G; Siragusa S; Mariani G; Cottone M
    Dig Liver Dis; 2001 Oct; 33(7):559-62. PubMed ID: 11816544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.
    Ravin AJ; Edwards RP; A Krohn M; Kelley JR; Christopherson WA; Roberts JM
    Obstet Gynecol; 2002 Dec; 100(6):1285-9. PubMed ID: 12468175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.